HomeAX9 • FRA
add
Akebia Therapeutics Inc
Previous close
€1.52
Day range
€1.38 - €1.38
Year range
€0.78 - €2.59
Market cap
412.25M USD
Avg Volume
730.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 46.50M | -17.26% |
Operating expense | 48.47M | 9.39% |
Net income | -22.80M | -3,814.01% |
Net profit margin | -49.04 | -4,599.08% |
Earnings per share | -0.10 | — |
EBITDA | -754.00K | -106.10% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 51.87M | 20.84% |
Total assets | 220.67M | -8.70% |
Total liabilities | 269.86M | -0.89% |
Total equity | -49.18M | — |
Shares outstanding | 236.23M | — |
Price to book | -6.90 | — |
Return on assets | -11.80% | — |
Return on capital | -26.25% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -22.80M | -3,814.01% |
Cash from operations | -4.47M | -93.50% |
Cash from investing | -2.00K | — |
Cash from financing | 22.32M | 1,830.62% |
Net change in cash | 17.86M | 596.30% |
Free cash flow | 21.78M | 68.40% |
About
Founded
Jan 1, 2007
Headquarters
Website
Employees
181
